Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stewart Gaede

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|December 22, 2018
[<sup>18</sup>F]FDG cardiac PET imaging in a canine model of radiation-induced cardiovascular disease associated with breast cancer radiotherapyOmar El-Sherif, Ilma Xhaferllari, Jane Sykes, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Acta Oncologica (Stockholm, Sweden)|March 31, 2017
Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapyHilâl Tekatli, Shyama U Tetar, Timothy K Nguyen, et al.
Advances in Radiation Oncology|April 18, 2022
Multimodality Imaging Assessment of the Heart Before and After Stage III Non-small Cell Lung Cancer Radiation TherapyOi-Wai Chau, Ali Islam, Edward Yu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 26, 2021
Intrafraction motion monitoring to determine PTV margins in early stage breast cancer patients receiving neoadjuvant partial breast SABRMatthew Mouawad, Owen Lailey, Per Poulsen, et al.
Frontiers in Oncology|March 30, 2026
Analyzing the effect of neoadjuvant stereotactic ablative body radiotherapy on pancreatic tumor perfusion using computed tomography perfusionJin-Young Bang, Dan Breadner, Timothy Nguyen, et al.
BMC Cancer|December 16, 2014
Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trialDouglas A Hoover, Dante Pi Capaldi, Khadija Sheikh, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
American Journal of Physiology. Heart and Circulatory Physiology|December 22, 2018
[<sup>18</sup>F]FDG cardiac PET imaging in a canine model of radiation-induced cardiovascular disease associated with breast cancer radiotherapyOmar El-Sherif, Ilma Xhaferllari, Jane Sykes, et al.
Radiation Oncology (London, England)|January 14, 2021
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [<sup>18</sup>F]FDG PET and CT perfusion: a prospective exploratory clinical studyDae-Myoung Yang, David A Palma, Keith Kwan, et al.
JAMA Oncology|February 22, 2019
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical TrialDavid A Palma, Timothy K Nguyen, Alexander V Louie, et al.
BMC Cancer|December 13, 2019
Assessment of precision irradiation in early non-small cell lung cancer and interstitial lung disease (ASPIRE-ILD): study protocol for a phase II trialDavid A Palma, Hanbo Chen, Houda Bahig, et al.
BMC Cancer|July 25, 2012
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trialDavid A Palma, Cornelis J A Haasbeek, George B Rodrigues, et al.
Acta Oncologica (Stockholm, Sweden)|March 31, 2017
Optimizing SABR delivery for synchronous multiple lung tumors using volumetric-modulated arc therapyHilâl Tekatli, Shyama U Tetar, Timothy K Nguyen, et al.
Advances in Radiation Oncology|April 18, 2022
Multimodality Imaging Assessment of the Heart Before and After Stage III Non-small Cell Lung Cancer Radiation TherapyOi-Wai Chau, Ali Islam, Edward Yu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 26, 2021
Intrafraction motion monitoring to determine PTV margins in early stage breast cancer patients receiving neoadjuvant partial breast SABRMatthew Mouawad, Owen Lailey, Per Poulsen, et al.
Frontiers in Oncology|March 30, 2026
Analyzing the effect of neoadjuvant stereotactic ablative body radiotherapy on pancreatic tumor perfusion using computed tomography perfusionJin-Young Bang, Dan Breadner, Timothy Nguyen, et al.
BMC Cancer|December 16, 2014
Functional lung avoidance for individualized radiotherapy (FLAIR): study protocol for a randomized, double-blind clinical trialDouglas A Hoover, Dante Pi Capaldi, Khadija Sheikh, et al.
Pageof 8